The Role of Induction Therapy for Sinonasal Cancers
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Oncology
Link
https://link.springer.com/content/pdf/10.1007/s11864-022-01046-z.pdf
Reference32 articles.
1. Turner JH, Reh DD. Incidence and survival in patients with sinonasal cancer: a historical analysis of population-based data. Head Neck. 2012;34:877–85.
2. Sanghvi S, Khan MN, Patel NR, Yeldandi S, Baredes S, Eloy JA. Epidemiology of sinonasal squamous cell carcinoma: a comprehensive analysis of 4994 patients. Laryngoscope. 2014;124(1):76–83. https://doi.org/10.1002/lary.24264.
3. Ansa B, Goodman M, Ward K, Kono SA, Owonikoko TK, Higgins K, Beitler JJ, Grist W, Wadsworth T, el-Deiry M, Chen AY, Khuri FR, Shin DM, Saba NF. Paranasal sinus squamous cell carcinoma incidence and survival based on Surveillance, Epidemiology, and End Results data, 1973 to 2009. Cancer. 2013;119(14):2602–10. https://doi.org/10.1002/cncr.28108.
4. •• Abdelmeguid AS, Teeramatwanich W, Roberts DB, et al. Neoadjuvant chemotherapy for locoregionally advanced squamous cell carcinoma of the paranasal sinuses. Cancer. 2021;127(11):1788–95. https://doi.org/10.1002/cncr.33452. This is the largest retrospective study available in recent literature for role of IC in SNSCC. It showed improved survival outcomes in patients with at least stable disease in response to IC. Also it showed that there was no significant difference in outcomes between post-IC treatment modality. It also showed an improvement in orbital preservation rates with IC
5. • Murr AT, Lenze NR, Weiss JM, et al. Sinonasal squamous cell carcinoma survival outcomes following induction chemotherapy vs standard of care therapy. Otolaryngol Head Neck Surg: official journal of american academy of otolaryngology-head and neck surgery. 2022;167:846–51. https://doi.org/10.1177/01945998221083097. This study showed improvement in 3-year OS with IC compared to current standard of care through 1:1 matched analysis
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Induction Chemotherapy for Sinonasal Tumors in Patients Presenting with Brain Invasion and/or Neurological Deficits;Journal of Neurological Surgery Part B: Skull Base;2023-09-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3